Science Explorer Interactive view Map
Company · Vancouver · Canada

Acuitas Therapeutics (Canada)

acuitastx.comROR OpenAlex
Research works
51
▲ 90% vs 2013–17
Citations
5.7k
111.2 per fractional work
Top-10% rate
61.6%
record average 16.5%
Open access
74%
world 28%

Not ranked overall: Acuitas Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.83× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.52× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 18.25× its world share, 5 worksImmunology and Micro…Neuroscience: 0.78× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.42× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.28× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.24× its world share, 1 worksEngineeringEnvironmental Science: 0.14× its world share, 0 worksEnvironmental ScienceMedicine: 2.32× its world share, 11 worksMedicineSocial Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 18.2×. Every wedge is a field page.

Who are the top researchers at Acuitas Therapeutics (Canada)?

Ranked on the composite score, Ying K. Tam lead among researchers whose main affiliation is Acuitas Therapeutics (Canada).

  1. 1 Ying K. Tam Canada · #155,446 worldwide 387 citations · 20 works
All ranked researchers at Acuitas Therapeutics (Canada)

Which keywords describe research at Acuitas Therapeutics (Canada)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine, Pathogenesis, Coronavirus, Immunity, Immune Response, Pandemic and SARS-CoV-2.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Epidemiology7▲ 7.0×21 topics
  2. Vaccine6▲ 63×7 topics
  3. Pathogenesis4▲ 34×6 topics
  4. Coronavirus4▲ 75×2 topics
  5. Immune Response4▲ 27×9 topics
  6. Immunity4▲ 38×2 topics
  7. Pandemic3▲ 11×3 topics
  8. SARS-CoV-23▲ 35×3 topics
  9. Gene Therapy3▲ 54×2 topics
  10. ACE2 Receptor2▲ 41×2 topics
  11. Viral Transmission2▲ 65×2 topics
  12. Cancer Immunotherapy2▲ 60×3 topics
  13. Innate Immunity2▲ 29×5 topics
  14. antibody2▲ 86×1 topic
  15. spike protein2▲ 86×1 topic
  16. RNA Interference2▲ 91×1 topic
  17. siRNA Delivery2▲ 130×1 topic
  18. Metagenomics2▲ 79×2 topics
  19. Antigen Presentation2▲ 77×2 topics
  20. Genomic Sequencing2▲ 60×3 topics
  21. Circovirus2▲ 209×1 topic
  22. Porcine Reproductive and Respiratory Syndrome Virus2▲ 209×1 topic
  23. Dendritic Cells2▲ 66×1 topic
  24. Tumor Antigen2▲ 96×1 topic
  25. Infection1▲ 23×2 topics
  26. Norovirus1▲ 97×1 topic
  27. Rotavirus1▲ 97×1 topic

Which research topics does Acuitas Therapeutics (Canada) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, RNA Interference and Gene Delivery, Animal Virus Infections Studies and Immunotherapy and Immune Responses.

SARS-CoV-2 and COVID-19 Research: 2 fractional worksRNA Interference and Gene Delivery: 2 fractional worksAnimal Virus Infections Studies: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksViral gastroenteritis research and epidemiology: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksHerpesvirus Infections and Treatments: 1 fractional worksVirus-based gene therapy research: 1 fractional worksImmune Cell Function and Interaction: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional works
Infectious DiseasesMolecular BiologyAnimal Science and ZoologyImmunology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  2. 2 RNA Interference and Gene Delivery Molecular Biology 2 works
  3. 3 Animal Virus Infections Studies Animal Science and Zoology 2 works
  4. 4 Immunotherapy and Immune Responses Immunology 2 works
  5. 5 Viral gastroenteritis research and epidemiology Infectious Diseases 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Herpesvirus Infections and Treatments Epidemiology 1 works
  8. 8 Virus-based gene therapy research Genetics 1 works
  9. 9 Immune Cell Function and Interaction Immunology 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.8%not open26.2%

World: 28% of research is openly available.

with international co-authors79.6%domestic only20.4%

World: 19% is written across borders.

How has Acuitas Therapeutics (Canada)'s research output changed?

Output in 2018–2022 was 90% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vancouver

All research institutions in Vancouver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.